Resonant Therapeutics
Biotechnology ResearchTexas, United States2-10 Employees
The Resonant platform generates antibodies to targets which other technologies have missed and cutting years off the discovery process.
Insights
Innovative Platform Resonant Therapeutics utilizes a proprietary platform that accelerates antibody discovery by identifying targets overlooked by traditional methods, positioning it as a leader in innovative biotech solutions.
Strategic Partnerships The company's recognition through awards and participation in JLABS incubator highlights strong industry validation and opportunities for collaboration with major players in the biotech ecosystem.
Growing Investment With recent institutional funding from Mercury Fund and participating in competitive award programs, Resonant is positioned for growth and potential expansion into new markets focusing on novel therapeutics.
Market Positioning Operating in a competitive sector with similar-sized companies, Resonant’s focus on specialized antibody discovery offers a niche for targeted outreach to biotech firms seeking cutting-edge research partners.
Technology Stack The adoption of cloud-based technologies and modern web tools indicates a digitally savvy organization, which can be leveraged to enhance partnerships and streamline joint ventures in research initiatives.
Similar companies to Resonant Therapeutics
Mnemo Therapeutics
$1M$10MIktos
$1M$10MGenialis
$1M$10MInsilico Medicine
$1B$10BGammaDelta Therapeutics
$1MLegend Biotech
$250M$500MOmina Technologies
$1MUnited Biopharma
$10M$25M
Resonant Therapeutics Tech Stack
Resonant Therapeutics uses 8 technology products and services including jsDelivr, cdnjs, WordPress, and more. Explore Resonant Therapeutics's tech stack below.
- jsDelivrContent Delivery Network
- cdnjsContent Delivery Network
- WordPressContent Management System
- oEmbedDev Tools
- Google WorkspaceEmail
- Font AwesomeFont Scripts
- Google CloudInfrastructure As A Service
- WebflowPage Builders
Media & News
Resonant Therapeutics's Email Address Formats
Resonant Therapeutics uses at least 1 format(s):
| Resonant Therapeutics Email Formats | Percentage |
| FLast@resonantrx.com | 38% |
| First@resonantrx.com | 12% |
| FLast@resonantrx.com | 38% |
| First@resonantrx.com | 12% |
Frequently Asked Questions
What is Resonant Therapeutics's official website and social media links?
Resonant Therapeutics's official website is resonantrx.com and has social profiles on LinkedInCrunchbase.What is Resonant Therapeutics's SIC code NAICS code?
Resonant Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Resonant Therapeutics have currently?
As of December 2025, Resonant Therapeutics has approximately 5 employees across 1 continents, including North America. Key team members include Executive Director, Head Of Antibody Discovery And Engineering: S. S.Executive Director, Cancer Biology: O. D.Principal Scientist: B. C.. Explore Resonant Therapeutics's employee directory with LeadIQ.What industry does Resonant Therapeutics belong to?
Resonant Therapeutics operates in the Biotechnology Research industry. What technology does Resonant Therapeutics use?
Resonant Therapeutics's tech stack includes jsDelivrcdnjsWordPressoEmbedGoogle WorkspaceFont AwesomeGoogle CloudWebflow. What is Resonant Therapeutics's email format?
Resonant Therapeutics's email format typically follows the pattern of FLast@resonantrx.com. Find more Resonant Therapeutics email formats with LeadIQ. How much funding has Resonant Therapeutics raised to date?
As of December 2025, Resonant Therapeutics has raised $2.5M in funding. The last funding round occurred on Oct 28, 2021 for $2.5M.When was Resonant Therapeutics founded?
Resonant Therapeutics was founded in 2015.
Company Overview
- Website
- resonantrx.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2015
- Employees
- 2-10
Funding & Financials
- $2.5M
Resonant Therapeutics has raised a total of $2.5M of funding over 3 rounds. Their latest funding round was raised on Oct 28, 2021 in the amount of $2.5M.
- $1M$10M
Resonant Therapeutics's revenue is estimated to be in the range of $1M$10M
Funding & Financials
- $2.5M
Resonant Therapeutics has raised a total of $2.5M of funding over 3 rounds. Their latest funding round was raised on Oct 28, 2021 in the amount of $2.5M.
- $1M$10M
Resonant Therapeutics's revenue is estimated to be in the range of $1M$10M
Company Leadership
S. S.Executive Director, Head Of Antibody Discovery And Engineering
O. D.Executive Director, Cancer Biology
B. C.Principal Scientist
Employee Directory
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
